These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7880883)

  • 1. Mouse cells with null p53 mutation have all p53 isoforms deleted and lose negative growth control.
    Selkirk JK; He C; Merrick BA
    Appl Theor Electrophor; 1994; 4(2):89-93. PubMed ID: 7880883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle control of p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. II. Requirement for cell cycle progression.
    Deppert W; Buschhausen-Denker G; Patschinsky T; Steinmeyer K
    Oncogene; 1990 Nov; 5(11):1701-6. PubMed ID: 2267136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered protein synthesis in p53 null and hemizygous transgenic mouse embryonic fibroblasts.
    He C; Merrick BA; Patterson RM; Selkirk JK
    Appl Theor Electrophor; 1995; 5(1):15-24. PubMed ID: 8534750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor p53 gene forms multiple isoforms: evidence for single locus origin and cytoplasmic complex formation with heat shock proteins.
    Selkirk JK; He C; Patterson RM; Merrick BA
    Electrophoresis; 1996 Nov; 17(11):1764-71. PubMed ID: 8982609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
    Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
    Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-ray-induced cell killing and chromosome abnormalities in the bone marrow of p53-deficient mice.
    Wang L; Cui Y; Lord BI; Roberts SA; Potten CS; Hendry JH; Scott D
    Radiat Res; 1996 Sep; 146(3):259-66. PubMed ID: 8752303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
    Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation.
    Albor A; Flessate DM; Soussi T; Notario V
    Cancer Res; 1994 Aug; 54(16):4502-7. PubMed ID: 8044802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.
    Harvey M; Sands AT; Weiss RS; Hegi ME; Wiseman RW; Pantazis P; Giovanella BC; Tainsky MA; Bradley A; Donehower LA
    Oncogene; 1993 Sep; 8(9):2457-67. PubMed ID: 8103211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression.
    Armata HL; Garlick DS; Sluss HK
    Cancer Res; 2007 Dec; 67(24):11696-703. PubMed ID: 18089799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
    Wesierska-Gadek J; Schmid G
    Cell Mol Biol Lett; 2001; 6(2):117-40. PubMed ID: 11544635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
    Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE
    Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53.
    Komarova EA; Diatchenko L; Rokhlin OW; Hill JE; Wang ZJ; Krivokrysenko VI; Feinstein E; Gudkov AV
    Oncogene; 1998 Sep; 17(9):1089-96. PubMed ID: 9764819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of mouse hepatocyte proliferation and ploidy by p53 and p53ser246 mutation in vivo.
    Yin L; Ghebranious N; Chakraborty S; Sheehan CE; Ilic Z; Sell S
    Hepatology; 1998 Jan; 27(1):73-80. PubMed ID: 9425920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
    Oakley R; Phillips E; Hooper R; Wilson D; Partridge M
    Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated mutagenesis and decreased DNA repair at a transgene are associated with proliferation but not apoptosis in p53-deficient cells.
    Bielas JH; Heddle JA
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12853-8. PubMed ID: 14569010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyomavirus large T antigen overcomes p53 dependent growth arrest.
    Doherty J; Freund R
    Oncogene; 1997 Apr; 14(16):1923-31. PubMed ID: 9150359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage.
    Kurdistani SK; Arizti P; Reimer CL; Sugrue MM; Aaronson SA; Lee SW
    Cancer Res; 1998 Oct; 58(19):4439-44. PubMed ID: 9766676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient stabilization of p53 in non-small cell lung carcinoma cultures arrested for growth by retinoic acid.
    Maxwell SA; Mukhopadhyay T
    Exp Cell Res; 1994 Sep; 214(1):67-74. PubMed ID: 8082749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.